Reducing Hemarthrosis in High Tibial Osteotomy and Tibial Tubercle Osteotomy



Status:Recruiting
Healthy:No
Age Range:18 - 60
Updated:10/19/2018
Start Date:June 26, 2018
End Date:June 2019
Contact:Kamali Thompson
Email:Kamali.Thompson@nyumc.org
Phone:646 501 8543

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Reducing Hemarthrosis in High Tibial Osteotomy and Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid

The purpose of the proposed study is to see if giving intravenous tranexamic acid (TXA) to
patients undergoing osteotomies will decrease bleeding in the joint and decrease post
operative pain. In order to evaluate the effectiveness two groups: one group will have a high
tibial osteotomy surgery and one group will have a tibial tubercle osteotomy surgery.
Investigators will compare knee swelling, side effects, and pain scores at 24 hours, 48
hours, and 7 days between both groups of patients.


Inclusion Criteria:

- Patients undergoing a high tibial osteotomy (HTO)

- Patients undergoing tibial tubercle osteotomy (TTO) with or without medial
patello-femoral ligament (MPFL) reconstruction

Exclusion Criteria:

- Legally incompetent or mentally impaired (e.g., minors, Alzheimer's subjects,
dementia, etc.)

- Younger than 18 years of age

- Older than 60 years of age

- Any patient considered a vulnerable subject

- Have bleeding or clotting disorder

- Preoperative anticoagulation therapy

- Abnormal coagulation profile

- Renal disorder or insufficiency

- Sickle cell disease
We found this trial at
1
site
New York University School of Medicine
550 1st Ave
New York, New York 10016
(212) 263-7300
Principal Investigator: Michael Alaia, MD
Phone: 646-501-8543
New York University School of Medicine NYU School of Medicine has a proud history that...
?
mi
from
New York, NY
Click here to add this to my saved trials